Treatment PTS of the Arm
ÎIn patients who have PTS of the arm, the ACCP suggests a trial of compression bandages or sleeves to reduce symptoms (2-C).
ÎIn patients with PTS of the arm, the ACCP suggests AGAINST treatment with venoactive medications (2-C).
Splanchnic Vein Thrombosis
ÎIn patients with symptomatic splanchnic vein thrombosis (portal, mesenteric, and/or splenic vein thromboses), the ACCP recommends anticoagulation over no anticoagulation (1-B).
ÎIn patients with incidentally detected splanchnic vein thrombosis (portal, mesenteric, and/or splenic vein thromboses), the ACCP suggests NO anticoagulation over anticoagulation (2-C).
Hepatic Vein Thrombosis
ÎIn patients with symptomatic hepatic vein thrombosis, the ACCP suggests anticoagulation over no anticoagulation (2-C).
ÎIn patients with incidentally detected hepatic vein thrombosis, the ACCP suggests NO anticoagulation over anticoagulation (2-C).
Phases of Anticoagulation Initial
(0 to ~7 days) Parenterala
(~7 days to ~3 months) Long-Term
(~3 months to indefinite) Extended Vitamin K antagonist or other agentb a Heparin, LMWH, fondaparinux b Includes LMWH, dabigatran, rivaroxaban
14
